{"entity":{"type":"insider","cik":"0001441632","url":"/insider/0001441632","json_url":"/insider/0001441632.json","name":"Carmichael Clare","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":22,"first":"2010-08-17","last":"2017-03-01","span_basis":"filed_date"},"name_variants":[{"name":"Carmichael Clare","source":"filing","n_filings":22,"first_seen":"2010-08-17","last_seen":"2017-03-01"}],"transactions":[{"id":4927715,"accession":"0000899866-17-000055","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899866-17-000055","line_url":"/filing/0000899866-17-000055#line-4","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":404.0,"shares_display":"404","price_per_share":132.5,"price_display":"132.50","price_state":"stated","total_value":53530.0,"total_display":"53,530.00","total_whole":"53,530","shares_owned_after":39161.0,"shares_owned_after_display":"39,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-01","scope":"insider"},{"id":4927707,"accession":"0000899866-17-000055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000055","line_url":"/filing/0000899866-17-000055#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":915.0,"shares_display":"915","price_per_share":131.71,"price_display":"131.71","price_state":"stated","total_value":120514.65,"total_display":"120,514.65","total_whole":"120,515","shares_owned_after":33065.0,"shares_owned_after_display":"33,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":4927699,"accession":"0000899866-17-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000055","line_url":"/filing/0000899866-17-000055#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":860.0,"shares_display":"860","price_per_share":131.2,"price_display":"131.20","price_state":"stated","total_value":112832.0,"total_display":"112,832.00","total_whole":"112,832","shares_owned_after":33980.0,"shares_owned_after_display":"33,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":5114600,"accession":"0000899866-17-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-17-000038","line_url":"/filing/0000899866-17-000038#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":167.0,"shares_display":"167","price_per_share":126.84,"price_display":"126.84","price_state":"stated","total_value":21182.28,"total_display":"21,182.28","total_whole":"21,182","shares_owned_after":34840.0,"shares_owned_after_display":"34,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-10","scope":"insider"},{"id":5346650,"accession":"0000899866-17-000031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-17-000031","line_url":"/filing/0000899866-17-000031#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":128.09,"price_display":"128.09","price_state":"stated","total_value":21262.94,"total_display":"21,262.94","total_whole":"21,263","shares_owned_after":35007.0,"shares_owned_after_display":"35,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-08","scope":"insider"},{"id":5346646,"accession":"0000899866-17-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-17-000031","line_url":"/filing/0000899866-17-000031","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3404.0,"shares_display":"3,404","price_per_share":125.69676850763807,"price_display":"125.70","price_state":"stated","total_value":427871.8,"total_display":"427,871.80","total_whole":"427,872","shares_owned_after":35197.0,"shares_owned_after_display":"35,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-08","scope":"insider","n_lines":2},{"id":3032970,"accession":"0000899866-16-000347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000347","line_url":"/filing/0000899866-16-000347#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":127.76,"price_display":"127.76","price_state":"stated","total_value":127760.0,"total_display":"127,760.00","total_whole":"127,760","shares_owned_after":38577.0,"shares_owned_after_display":"38,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-30","filed_date":"2016-09-01","scope":"insider"},{"id":2943230,"accession":"0000899866-16-000340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-16-000340","line_url":"/filing/0000899866-16-000340#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165.0,"shares_display":"165","price_per_share":137.14,"price_display":"137.14","price_state":"stated","total_value":22628.1,"total_display":"22,628.10","total_whole":"22,628","shares_owned_after":39577.0,"shares_owned_after_display":"39,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-08","filed_date":"2016-08-10","scope":"insider"},{"id":2585879,"accession":"0000899866-16-000266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-16-000266","line_url":"/filing/0000899866-16-000266#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1312.0,"shares_display":"1,312","price_per_share":138.91,"price_display":"138.91","price_state":"stated","total_value":182249.92,"total_display":"182,249.92","total_whole":"182,250","shares_owned_after":39742.0,"shares_owned_after_display":"39,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-01","scope":"insider"},{"id":2863331,"accession":"0000899866-16-000243","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899866-16-000243","line_url":"/filing/0000899866-16-000243","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2665.0,"shares_display":"2,665","price_per_share":138.052904315197,"price_display":"138.05","price_state":"stated","total_value":367910.99,"total_display":"367,910.99","total_whole":"367,911","shares_owned_after":34054.0,"shares_owned_after_display":"34,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-08","scope":"insider","n_lines":3},{"id":2863324,"accession":"0000899866-16-000243","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899866-16-000243","line_url":"/filing/0000899866-16-000243","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1993.0,"shares_display":"1,993","price_per_share":141.7649372804817,"price_display":"141.76","price_state":"stated","total_value":282537.52,"total_display":"282,537.52","total_whole":"282,538","shares_owned_after":36719.0,"shares_owned_after_display":"36,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-05","filed_date":"2016-02-08","scope":"insider","n_lines":6},{"id":2863306,"accession":"0000899866-16-000243","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-16-000243","line_url":"/filing/0000899866-16-000243","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":143.8355072463768,"price_display":"143.84","price_state":"stated","total_value":29773.95,"total_display":"29,773.95","total_whole":"29,774","shares_owned_after":26953.0,"shares_owned_after_display":"26,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-04","filed_date":"2016-02-08","scope":"insider","n_lines":2},{"id":8590738,"accession":"0000899866-15-000169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000169","line_url":"/filing/0000899866-15-000169#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":305.0,"shares_display":"305","price_per_share":168.62,"price_display":"168.62","price_state":"stated","total_value":51429.1,"total_display":"51,429.10","total_whole":"51,429","shares_owned_after":27156.0,"shares_owned_after_display":"27,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-03","scope":"insider"},{"id":8934726,"accession":"0000899866-15-000154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000154","line_url":"/filing/0000899866-15-000154#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":163.0,"shares_display":"163","price_per_share":190.01,"price_display":"190.01","price_state":"stated","total_value":30971.63,"total_display":"30,971.63","total_whole":"30,972","shares_owned_after":27461.0,"shares_owned_after_display":"27,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-07","filed_date":"2015-08-11","scope":"insider"},{"id":8234487,"accession":"0000899866-15-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000145","line_url":"/filing/0000899866-15-000145#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185.0,"shares_display":"185","price_per_share":196.52,"price_display":"196.52","price_state":"stated","total_value":36356.2,"total_display":"36,356.20","total_whole":"36,356","shares_owned_after":27624.0,"shares_owned_after_display":"27,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-04","filed_date":"2015-08-05","scope":"insider"},{"id":8653592,"accession":"0000899866-15-000070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-15-000070","line_url":"/filing/0000899866-15-000070#line-3","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":706.0,"shares_display":"706","price_per_share":180.34,"price_display":"180.34","price_state":"stated","total_value":127320.04,"total_display":"127,320.04","total_whole":"127,320","shares_owned_after":27809.0,"shares_owned_after_display":"27,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-03","scope":"insider"},{"id":8816526,"accession":"0000899866-15-000049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-15-000049","line_url":"/filing/0000899866-15-000049#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1490.0,"shares_display":"1,490","price_per_share":171.15,"price_display":"171.15","price_state":"stated","total_value":255013.5,"total_display":"255,013.50","total_whole":"255,014","shares_owned_after":21670.0,"shares_owned_after_display":"21,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-12","scope":"insider"},{"id":8875325,"accession":"0000899866-15-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000030","line_url":"/filing/0000899866-15-000030#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1665.0,"shares_display":"1,665","price_per_share":173.75,"price_display":"173.75","price_state":"stated","total_value":289293.75,"total_display":"289,293.75","total_whole":"289,294","shares_owned_after":23160.0,"shares_owned_after_display":"23,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-09","filed_date":"2015-02-09","scope":"insider"},{"id":8707487,"accession":"0000899866-15-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-15-000011","line_url":"/filing/0000899866-15-000011","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (EVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":207.0,"shares_display":"207","price_per_share":174.34927536231885,"price_display":"174.35","price_state":"stated","total_value":36090.3,"total_display":"36,090.30","total_whole":"36,090","shares_owned_after":16069.0,"shares_owned_after_display":"16,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-04","filed_date":"2015-02-05","scope":"insider","n_lines":2},{"id":6173181,"accession":"0000899866-14-000257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-14-000257","line_url":"/filing/0000899866-14-000257#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":196.25,"price_display":"196.25","price_state":"stated","total_value":1962500.0,"total_display":"1,962,500.00","total_whole":"1,962,500","shares_owned_after":16272.0,"shares_owned_after_display":"16,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-04","filed_date":"2014-12-08","scope":"insider"},{"id":6301839,"accession":"0000899866-14-000192","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000192","line_url":"/filing/0000899866-14-000192#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":304.0,"shares_display":"304","price_per_share":169.46,"price_display":"169.46","price_state":"stated","total_value":51515.84,"total_display":"51,515.84","total_whole":"51,516","shares_owned_after":16272.0,"shares_owned_after_display":"16,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6814488,"accession":"0000899866-14-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000176","line_url":"/filing/0000899866-14-000176#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184.0,"shares_display":"184","price_per_share":158.23,"price_display":"158.23","price_state":"stated","total_value":29114.32,"total_display":"29,114.32","total_whole":"29,114","shares_owned_after":16576.0,"shares_owned_after_display":"16,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-04","filed_date":"2014-08-05","scope":"insider"},{"id":6568486,"accession":"0000899866-14-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-14-000080","line_url":"/filing/0000899866-14-000080#line-2","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":305.0,"shares_display":"305","price_per_share":174.77,"price_display":"174.77","price_state":"stated","total_value":53304.85,"total_display":"53,304.85","total_whole":"53,305","shares_owned_after":16760.0,"shares_owned_after_display":"16,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-04","scope":"insider"},{"id":6359588,"accession":"0000899866-14-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899866-14-000049","line_url":"/filing/0000899866-14-000049","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1006.0,"shares_display":"1,006","price_per_share":155.5624652087475,"price_display":"155.56","price_state":"stated","total_value":156495.84,"total_display":"156,495.84","total_whole":"156,496","shares_owned_after":13771.0,"shares_owned_after_display":"13,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-07","filed_date":"2014-02-10","scope":"insider","n_lines":2},{"id":6543019,"accession":"0000899866-14-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899866-14-000027","line_url":"/filing/0000899866-14-000027#line-1","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":760.0,"shares_display":"760","price_per_share":153.63,"price_display":"153.63","price_state":"stated","total_value":116758.8,"total_display":"116,758.80","total_whole":"116,759","shares_owned_after":8703.0,"shares_owned_after_display":"8,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-05","scope":"insider"},{"id":4806803,"accession":"0000899866-13-000164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899866-13-000164","line_url":"/filing/0000899866-13-000164","is_derivative":false,"issuer_cik":"0000899866","issuer_name":"ALEXION PHARMACEUTICALS INC","issuer_ticker":"ALXN","issuer_name_source":null,"issuer_url":"/issuer/0000899866","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Common Stock, par value $.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1237.0,"shares_display":"1,237","price_per_share":107.5785044462409,"price_display":"107.58","price_state":"stated","total_value":133074.61,"total_display":"133,074.61","total_whole":"133,075","shares_owned_after":9500.0,"shares_owned_after_display":"9,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-30","filed_date":"2013-09-03","scope":"insider","n_lines":2},{"id":7760301,"accession":"0001179110-10-012822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-10-012822","line_url":"/filing/0001179110-10-012822","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001441632","owner_name":"Carmichael Clare","owner_display_name":"Carmichael Clare","owner_url":"/insider/0001441632","role":"Officer (SR VP, Human Resources)","role_mark":"O","role_mark_label":"Officer (SR VP, Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SR VP, Human Resources","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1318.0,"shares_display":"1,318","price_per_share":42.320933080424886,"price_display":"42.32","price_state":"stated","total_value":55778.9898,"total_display":"55,778.99","total_whole":"55,779","shares_owned_after":17483.0,"shares_owned_after_display":"17,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-16","filed_date":"2010-08-17","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000899866","name":"ALEXION PHARMACEUTICALS INC","url":"/issuer/0000899866","role":"Officer (EVP, Chief HR Officer)","n_filings":21,"first_seen":"2013-09-03","last_seen":"2017-03-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000884629","name":"WATSON PHARMACEUTICALS INC","url":"/issuer/0000884629","role":"Officer (SR VP, Human Resources)","n_filings":1,"first_seen":"2010-08-17","last_seen":"2010-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001441632","retrieved_at":"2026-08-26T12:47:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}